TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32934794

Group type: EXPERIMENTAL
Intervention: Hospital Elder Life Program (HELP)‐based paging system
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Family‐based paging system
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined HELP‐ and family‐based system
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: HELP-based paging system
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Family-based paging system
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Exploratory outcomes
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Hospital Elder Life Program (HELP)-based paging system
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined HELP- and family-based system
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Usual care, HELP-based paging system, family-based paging system, combined HELP- and family-based system
Number of subjects: 60
Study: 36237582

Group type: EXPERIMENTAL
Intervention: Shuanghuanghua granules (ultrafine preparation)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Shuanghuanghua granules (extract preparation)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Fengreganmao granules
Number of subjects: 126
Study: 32395750

Group type: EXPERIMENTAL
Intervention: Natural cycle frozen embryo transfer (NC-FET)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Modified natural cycle frozen embryo transfer (modified NC-FET) with subcutaneous hCG injection to trigger ovulation
Number of subjects: 248

Group type: COMPARATOR
Intervention: Modified natural cycle frozen embryo transfer (modified NC-FET)
Number of subjects: 248
Study: 34246214

Group type: EXPERIMENTAL
Intervention: Rupatadine fumarate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bepotastine besilate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32017251

Group type: EXPERIMENTAL
Intervention: Web-based program (4 education modules)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Routine care in clinics (control group)
Number of subjects: 71
Study: 35414541

Group type: EXPERIMENTAL
Intervention: Mindfulness course for 4 weeks
Number of subjects: 240

Group type: COMPARATOR
Intervention: Light physical exercise course for 4 weeks
Number of subjects: 240
Study: 34655533

Group type: EXPERIMENTAL
Intervention: Daratumumab plus lenalidomide and dexamethasone
Number of subjects: 737

Group type: COMPARATOR
Intervention: Lenalidomide and dexamethasone alone (control group)
Number of subjects: 737
Study: 32702919

Group type: EXPERIMENTAL
Intervention: Early mobilization
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Early nutrition combined with early mobilization
Number of subjects: 147

Group type: COMPARATOR
Intervention: Standard care (minimal exercises, experience‐based initiation and enrollment of nutrition support)
Number of subjects: 147
Study: 33560052

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg/day (n=2903)
Number of subjects: 30937

Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg/day (n=8407)
Number of subjects: 30937

Group type: EXPERIMENTAL
Intervention: Combination of telmisartan 80 mg/day and ramipril 10 mg/day (n=8334)
Number of subjects: 30937

Group type: COMPARATOR
Intervention: Placebo (n=2907)
Number of subjects: 30937

Group type: EXPERIMENTAL
Intervention: Achieved SBP levels
Number of subjects: 30937
Study: 33027246

Group type: EXPERIMENTAL
Intervention: Continuous Quality Improvement (CQI) intervention delivered by trained mentors using standard CQI tools over 19 months.
Number of subjects: 2160

Group type: COMPARATOR
Intervention: Usual standard of antenatal care (ANC) as control.
Number of subjects: 2160
Study: 35986410

Group type: EXPERIMENTAL
Intervention: Early CRRT
Number of subjects: 496

Group type: COMPARATOR
Intervention: Conventional-indicated CRRT
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Beta-blocker
Number of subjects: 496

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 496
Study: 34809689

Group type: EXPERIMENTAL
Intervention: Fermented Rhus verniciflua Stokes extract (FRVE) - 129 mg fustin and 59 mg fisetin, taken as two capsules once daily for 12 weeks
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo (lactose 627.0 mg), taken as two capsules once daily for 12 weeks
Number of subjects: 79
Study: 32659856

Group type: EXPERIMENTAL
Intervention: Lower arterial oxygenation target (8 kPa)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Higher arterial oxygenation target (12 kPa)
Number of subjects: 0
Study: 35731337

Group type: EXPERIMENTAL
Intervention: Robotic assisted Total Knee Arthroplasty - Group A (1st set of 25 cases)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Robotic assisted Total Knee Arthroplasty - Group B (2nd set of 25 cases)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Robotic assisted Total Knee Arthroplasty - Group C (3rd set of 25 cases)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Robotic assisted Total Knee Arthroplasty - Group A
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Robotic assisted Total Knee Arthroplasty - Group B
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Robotic assisted Total Knee Arthroplasty - Group C
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional jig-based Total Knee Arthroplasty
Number of subjects: 100
Study: 34111066

Group type: EXPERIMENTAL
Intervention: Muscle energy technique
Number of subjects: 56

Group type: COMPARATOR
Intervention: Mulligan mobilisation
Number of subjects: 56
Study: 35329194

Group type: EXPERIMENTAL
Intervention: Eight-week functional core stability training (CST) program based on rhythmic gymnastics technical requirements added to traditional RG training sessions.
Number of subjects: 45

Group type: COMPARATOR
Intervention: Traditional RG training sessions (Control Group).
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both groups (EG and CG).
Number of subjects: 45
Study: 34089698

Group type: EXPERIMENTAL
Intervention: Prenatal fetoscopic repair of open spina bifida
Number of subjects: 300

Group type: COMPARATOR
Intervention: Management of Myelomeningocele Study
Number of subjects: 300

Group type: COMPARATOR
Intervention: Post-Management of Myelomeningocele Study cohort
Number of subjects: 300
Study: 35385330

Group type: EXPERIMENTAL
Intervention: K-Vie™
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 34078426

Group type: EXPERIMENTAL
Intervention: Endoscopic vacuum therapy (EVT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Self‐expanding metal stents (SEMS)
Number of subjects: 40
Study: 35482987

Group type: EXPERIMENTAL
Intervention: Reishimmune-S 500 mg/day orally for 14 days
Number of subjects: 0
Study: 33031652

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 4716

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 4716
Study: 35305280

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 32757387

Group type: EXPERIMENTAL
Intervention: Immediate temporization
Number of subjects: 49

Group type: COMPARATOR
Intervention: Delayed temporization
Number of subjects: 49
Study: 34408823

Group type: EXPERIMENTAL
Intervention: BIT-mCI group (80 h of BIT followed by 20 h of mCIMT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: mCIMT-B group (80 h of mCIMT followed by 20 h of BIT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 20
Study: 32090766

Group type: EXPERIMENTAL
Intervention: 6-week internet-based self-help program
Number of subjects: 418

Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 418
Study: 34826137

Group type: EXPERIMENTAL
Intervention: Copenhagen Original Long Cut at pH 5.0
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Copenhagen Original Long Cut at pH 7.7
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Copenhagen Original Long Cut at pH 8.2
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Copenhagen Original Long Cut at pH 8.6
Number of subjects: 40
Study: 32534809

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg intravenously every 3 weeks
Number of subjects: 7
Study: 36356657

Group type: EXPERIMENTAL
Intervention: Efzofitimod 1 mg/kg
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Efzofitimod 3 mg/kg
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Efzofitimod 5 mg/kg
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Efzofitimod 3 mg/kg and 5 mg/kg
Number of subjects: 37
Study: 34411627

Group type: EXPERIMENTAL
Intervention: 15 µg fentanyl with 10 mg hyperbaric bupivacaine
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: 10 µg fentanyl with 10 mg hyperbaric bupivacaine
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: 7.5 µg fentanyl with 10 mg hyperbaric bupivacaine
Number of subjects: 124

Group type: COMPARATOR
Intervention: 0 µg fentanyl with 10 mg hyperbaric bupivacaine (Control Group IV)
Number of subjects: 124
Study: 32324238

Group type: EXPERIMENTAL
Intervention: High-dose azithromycin (20 mg/kg/d)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Standard-dose azithromycin (10 mg/kg/d)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 48
Study: 35511454

Group type: EXPERIMENTAL
Intervention: Nivolumab (NIVO) + RT + TMZ
Number of subjects: 716

Group type: COMPARATOR
Intervention: Placebo (PBO) + RT + TMZ
Number of subjects: 716

Group type: EXPERIMENTAL
Intervention: Nivolumab (NIVO) + RT + TMZ (patients without baseline corticosteroids)
Number of subjects: 716

Group type: COMPARATOR
Intervention: Placebo (PBO) + RT + TMZ (patients without baseline corticosteroids)
Number of subjects: 716
Study: 32370931

Group type: EXPERIMENTAL
Intervention: Incentive group (n = 44)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (n = 47)
Number of subjects: 91
Study: 33719473

Group type: EXPERIMENTAL
Intervention: In-person smoking cessation intervention
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Smartphone-based smoking cessation intervention
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 81
Study: 32553471

Group type: EXPERIMENTAL
Intervention: Oil-based contrast during HSG
Number of subjects: 1119

Group type: COMPARATOR
Intervention: Water-based contrast during HSG
Number of subjects: 1119
Study: 34637770

Group type: EXPERIMENTAL
Intervention: Hunger condition (fasting for 14 hours)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Satiated condition (eating breakfast before the study)
Number of subjects: 108
Study: 32174296

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy adapted for health anxiety (CBT-HA)
Number of subjects: 444

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 444
Study: 33443030

Group type: EXPERIMENTAL
Intervention: Facilitated cascade testing strategy (engagement strategies with a patient navigator, an educational video, and accessible genetic testing services)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Standard of care (proband‐mediated information sharing, sharing a family letter)
Number of subjects: 450
Study: 32479320

Group type: EXPERIMENTAL
Intervention: Neurofeedback training for left dorsolateral prefrontal cortex (DLPFC) activity
Number of subjects: 6
Study: 36178294

Group type: EXPERIMENTAL
Intervention: Nurse-driven patient empowerment intervention (NEI)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 178
Study: 34607194

Group type: EXPERIMENTAL
Intervention: Individual Opioid Drug Counseling (ODC) plus buprenorphine
Number of subjects: 357

Group type: COMPARATOR
Intervention: Buprenorphine alone
Number of subjects: 357
Study: 32869248

Group type: EXPERIMENTAL
Intervention: Additional depression prevention training (IG)
Number of subjects: 394

Group type: COMPARATOR
Intervention: Pain competence training (CG)
Number of subjects: 394
Study: 34329669

Group type: EXPERIMENTAL
Intervention: Unpleasant odor context
Number of subjects: 69

Group type: COMPARATOR
Intervention: Pleasant odor context
Number of subjects: 69

Group type: COMPARATOR
Intervention: No odor context
Number of subjects: 69
Study: 32350735

Group type: COMPARATOR
Intervention: Microporous polypropylene mesh (SP‐PPL)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Polytetrafluoroethylene mesh (LP‐PTFE)
Number of subjects: 52
Study: 36335278

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 99
Study: 33350604

Group type: EXPERIMENTAL
Intervention: Lactiplantibacillus plantarum 299 and 299v (Lp299 and Lp299v)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34730810

Group type: EXPERIMENTAL
Intervention: Buprenorphine-Clonidine-Dexamethasone (BCD) admixed with Bupivacaine (BPV)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Plain Bupivacaine (BPV)
Number of subjects: 98
Study: 33587286

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 36228577

Group type: EXPERIMENTAL
Intervention: Multimodal treatment (MT)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Aerobic training (AT)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Combination of multimodal treatment with aerobic training (CT)
Number of subjects: 105
Study: 32479641

Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 198

Group type: COMPARATOR
Intervention: Secukinumab
Number of subjects: 198
Study: 32532299

Group type: EXPERIMENTAL
Intervention: Females with borderline high and above total cholesterol (TC ≥ 200 mg/dL)
Number of subjects: 26378

Group type: EXPERIMENTAL
Intervention: Females with borderline high and above triglycerides (TG ≥ 150 mg/dL)
Number of subjects: 26378

Group type: EXPERIMENTAL
Intervention: Females with borderline high and above low-density lipoprotein cholesterol (LDL-C ≥ 130 mg/dL)
Number of subjects: 26378

Group type: EXPERIMENTAL
Intervention: Females with low high-density lipoprotein cholesterol (HDL-C < 40 mg/dL)
Number of subjects: 26378

Group type: COMPARATOR
Intervention: Males with borderline high and above TC, TG, and LDL-C
Number of subjects: 26378

Group type: EXPERIMENTAL
Intervention: Females with borderline high and above TC, TG, and LDL-C
Number of subjects: 26378

Group type: EXPERIMENTAL
Intervention: Risk factors for dyslipidemia in males
Number of subjects: 26378

Group type: EXPERIMENTAL
Intervention: Risk factors for dyslipidemia in females
Number of subjects: 26378
Study: 35581749

Group type: EXPERIMENTAL
Intervention: Evening testing (17:00–19:00) for knee extensors
Number of subjects: 27

Group type: COMPARATOR
Intervention: Morning testing (07:00–09:00) for knee extensors
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Evening testing (17:00–19:00) for elbow flexors
Number of subjects: 27

Group type: COMPARATOR
Intervention: Morning testing (07:00–09:00) for elbow flexors
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Evening testing (17:00–19:00) for biceps brachii
Number of subjects: 27

Group type: COMPARATOR
Intervention: Morning testing (07:00–09:00) for vastus lateralis
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Evening testing (17:00–19:00) for knee extension in males
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Evening testing (17:00–19:00) for knee extension in females
Number of subjects: 27
Study: 34815354

Group type: EXPERIMENTAL
Intervention: Avelumab alone (arm A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Avelumab combined with cetuximab (arm B)
Number of subjects: 60
Study: 33400656

Group type: EXPERIMENTAL
Intervention: Modular learning framework for classification with weak supervision using implicit pairwise labels.
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Modular training approach
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Method for estimating reusability of pretrained modules
Number of subjects: 10
Study: 33594443

Group type: EXPERIMENTAL
Intervention: Virtual Reality Gait Training (VRT)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Non-Virtual Reality Gait Training (non-VRT)
Number of subjects: 55
Study: 32634815

Group type: EXPERIMENTAL
Intervention: Medium Cut-Off (MCO) dialyzers
Number of subjects: 52

Group type: COMPARATOR
Intervention: High-Flux dialyzers
Number of subjects: 52
Study: 35491518

Group type: EXPERIMENTAL
Intervention: GIPR antagonist GIP(3‐30)NH2 (1,200 pmol/kg/min) with GLP‐1 infusion (0.75 pmol/kg/min)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: GIPR antagonist GIP(3‐30)NH2 with GLP‐1 infusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 33601214

Group type: EXPERIMENTAL
Intervention: Frozen vegetable-based meals
Number of subjects: 51

Group type: COMPARATOR
Intervention: Commercial sterilized meals in jars
Number of subjects: 51
Study: 35706870

Group type: EXPERIMENTAL
Intervention: Selenium 400 μg tablets, taken three times a week after each hemodialysis session for 3 months
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 78
Study: 33408365

Group type: EXPERIMENTAL
Intervention: Multi-locus negative frequency-dependent selection (NFDS) combined with asymmetrical recombination favoring deletion of accessory loci over insertion.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multi-locus negative frequency-dependent selection (NFDS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Symmetrical recombination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Asymmetrical recombination
Number of subjects: 0
Study: 34011404

Group type: EXPERIMENTAL
Intervention: Protective ventilation group with tidal volume (VT) of 7 ml/kg of predicted body weight (PBW) and optimal PEEP
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Protective ventilation group
Number of subjects: 64

Group type: COMPARATOR
Intervention: Traditional ventilation group with tidal volume (VT) of 9 ml/kg of predicted body weight (PBW)
Number of subjects: 64
Study: 32179237

Group type: EXPERIMENTAL
Intervention: Eye movements intervention during recall of aversive memory
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control condition (recall without eye movements)
Number of subjects: 68
Study: 36017005

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 33881796

Group type: EXPERIMENTAL
Intervention: linagliptin
Number of subjects: 360

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 360
Study: 32315648

Group type: EXPERIMENTAL
Intervention: Floor Sitting-Rising Test (SRT)
Number of subjects: 240
Study: 34686780

Group type: EXPERIMENTAL
Intervention: sorafenib
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: selective internal radiation therapy
Number of subjects: 376

Group type: COMPARATOR
Intervention: baseline imaging features
Number of subjects: 376
Study: 33571839

Group type: EXPERIMENTAL
Intervention: Hysteroscopic morcellation with the TruClearTM 8.0 Tissue Removal System
Number of subjects: 83

Group type: COMPARATOR
Intervention: Bipolar resection with a rigid 8.5‐mm resectoscope
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Hysteroscopic morcellation
Number of subjects: 83
Study: 33130569

Group type: EXPERIMENTAL
Intervention: Psychosexual education about medical and behavioural treatment options for sexual dysfunction delivered by a haematology nurse consultant; emotionally focused therapy-based relationship education programme for couples delivered by a clinical psychologist (four sessions of 1.5 hours each).
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Psychosexual intervention for couples post-transplantation.
Number of subjects: 15
Study: 34165763

Group type: EXPERIMENTAL
Intervention: Weight-bearing (WB) exercise
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Non-weight-bearing (NON-WB) exercise
Number of subjects: 15
Study: 34489366

Group type: EXPERIMENTAL
Intervention: mHealth-facilitated personalized intervention
Number of subjects: 21
Study: 34826995

Group type: EXPERIMENTAL
Intervention: Meditation training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine care (without meditation)
Number of subjects: 40
Study: 33688068

Group type: EXPERIMENTAL
Intervention: Personalised, trauma-informed yoga
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Group exercise
Number of subjects: 21
Study: 33767247

Group type: EXPERIMENTAL
Intervention: Traditional Medicine
Number of subjects: 177
Study: 32050105

Group type: EXPERIMENTAL
Intervention: Photochemotherapy (PCT) with toluidine blue photosensitizer and 660 nm diode laser
Number of subjects: 50

Group type: COMPARATOR
Intervention: Local antibiotic therapy (LAT) with metronidazole gel
Number of subjects: 50
Study: 34455545

Group type: EXPERIMENTAL
Intervention: Hatha yoga
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 78

Group type: COMPARATOR
Intervention: Stretching-toning control group
Number of subjects: 78
Study: 33573612

Group type: EXPERIMENTAL
Intervention: Colostrum avoidance practice
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Reasons for discarding colostrum
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Factors associated with less likelihood of discarding colostrum
Number of subjects: 398
Study: 32886267

Group type: EXPERIMENTAL
Intervention: Oral Semaglutide
Number of subjects: 0
Study: 35598005

Group type: EXPERIMENTAL
Intervention: 40mg of methylprednisolone once a day for 5 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 80mg of methylprednisolone once a day for 5 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 120mg of methylprednisolone once a day for 5 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard ICU patient care + 100ml of normal saline once a day for 5 days (Control group)
Number of subjects: 0
Study: 33493153

Group type: EXPERIMENTAL
Intervention: Educational intervention directed towards staff members focusing on palliative care
Number of subjects: 203

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 203
Study: 32788083

Group type: EXPERIMENTAL
Intervention: G-MEDSS (Computerised Clinical Decision Support System)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: G-MEDSS
Number of subjects: 26
Study: 36085067

Group type: EXPERIMENTAL
Intervention: Progressive Goal Attainment Program (PGAP) intervention consisting of a maximum of 10 weekly individual sessions provided by a trained PGAP professional.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting-list control group (care as usual).
Number of subjects: 0